Expectant Management of Ectopic Pregnancy

Ectopic Pregnancy Clinical Trial

Official title:

Evaluation of Expectant Management in Women Diagnosed With a Tubal Ectopic Pregnancy at Ain-Shams University Maternity Hospital Over the Period From January 1, 2016 to December 31, 2020

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04975984
• Other study ID #: ASU FM1
• Status: Not yet recruiting
• Start date: July 20, 2021
• Est. completion date: December 31, 2021

Study information

• Verified date: July 2021
• Source: Ain Shams University
• Contact: Radwa Rasheedy, MD
• Phone: 01283492979
• Email: radwaebed[@]yahoo.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to assess the efficacy and safety of expectant management in the treatment of tubal ectopic pregnancy and identification of different factors that can be used to predict its success.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: December 31, 2021
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• all women who underwent expectant management as the first line of management offered after optimal counseling during the period from January 1, 2016 to December 31, 2020.

1. Hemodynamically stable with confirmed diagnosis of ectopic pregnancy on ultrasound scan.

2. No significant pelvic pain.

3. No hemoperitoneum.

4. No fetal heart in the ectopic pregnancy.

5. HCG level <5000 IU/L.

6. Expectant management was the first line of management offered to the patient after optimal counseling.

Exclusion Criteria:

1. all women with non tubal ectopic pregnancy

2. all women with tubal ectopic pregnancy that recieved medical or surgical treatment as 1st line treatment

Related Conditions & MeSH terms

• Ectopic Pregnancy
• Pregnancy, Ectopic

Intervention

Diagnostic Test:
• qualitative hCG levels and ultrasound criteria
detect upper limit of qualitative hCG levels associated with successful expectant management of ectopic pregnancy

Locations

Country	Name	City	State
Egypt	Ain Shams university maternity hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	resolution of hCG level	hCG levels measured every week till negative less than (<20 IU/l) up to 12 weeks	up to 12 weeks